Medicare Part B Rx Vendors Should Cover All Single Source Drugs, BIO Says
Executive Summary
Medicare should require Part B drug vendors to offer at least one formulation of each single-source drug and biologic under the competitive acquisition program, the Biotechnology Industry Organization said